CASTLEARK MANAGEMENT LLC – Neurocrine Biosciences, Inc. Transaction History
CASTLEARK MANAGEMENT LLC portfolio value:
$5.60M
portfolio value
CASTLEARK MANAGEMENT LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.28% | -1.23K shares | 341K | $106.21 | 52.77K |
| Q2 2022 | share | Increase | +19.36% | 8.76K shares | 1.02M | $97.48 | 54K |
| Q1 2022 | share | Increase | 0.00% | 45.24K shares | 4.24M | $93.75 | 45.24K |
| Q4 2021 | share | Decrease | -100.00% | -1.40K shares | -135K | $84.63 | 0 |
| Q3 2021 | share | 0.00% | 0 shares | -2K | $95.91 | 1.40K | |
| Q2 2021 | share | 0.00% | 0 shares | 0 | $97.32 | 1.40K | |
| Q1 2021 | share | Decrease | -55.82% | -1.77K shares | -168K | $97.25 | 1.40K |
| Q4 2020 | share | 0.00% | 0 shares | -1K | $95.85 | 3.18K | |
| Q3 2020 | share | Decrease | -77.96% | -11.25K shares | -1.45M | $96.16 | 3.18K |
| Q2 2020 | share | Decrease | -75.11% | -43.54K shares | -3.25M | $122 | 14.43K |
| Q1 2020 | share | Decrease | -38.31% | -35.99K shares | -5.08M | $86.55 | 57.97K |
| Q4 2019 | share | Decrease | -9.67% | -10.05K shares | 727K | $107.49 | 93.96K |
| Q3 2019 | share | Increase | 0.00% | 104.02K shares | 9.37M | $90.11 | 104.02K |
| Q1 2019 | share | Decrease | -100.00% | -15.77K shares | -1.12M | $88.1 | 0 |
| Q4 2018 | share | Decrease | -66.20% | -30.89K shares | -4.61M | $71.41 | 15.77K |
| Q3 2018 | share | Increase | +9.88% | 4.19K shares | 1.56M | $122.95 | 46.66K |
| Q2 2018 | share | Decrease | -7.57% | -3.48K shares | 361K | $98.24 | 42.47K |
| Q1 2018 | share | Increase | +55.13% | 16.33K shares | 1.51M | $82.93 | 45.95K |
| Q4 2017 | share | Increase | 0.00% | 29.62K shares | 2.29M | $77.59 | 29.62K |